Similar articles

• Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.

  Tancer RS. Tancer RS. Clin Ther. 1993 Nov-Dec;15(6):1177-84; discussion 1120. Clin Ther. 1993. PMID: 8111813
• Sublicense or supply agreement? Supreme Court of Canada interpretation benefits generic pharmaceutical industry.

  Burshtein S. Burshtein S. Food Drug Law J. 1999;54(1):73-91. Food Drug Law J. 1999. PMID: 11758562 No abstract available.
• Drug patent protection: how long is long enough?

  Sibbald B. Sibbald B. CMAJ. 2001 May 1;164(9):1331. CMAJ. 2001. PMID: 11341146 Free PMC article. No abstract available.
• Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.

  Teufel AT. Teufel AT. J Contemp Health Law Policy. 2006 Spring;22(2):383-408. J Contemp Health Law Policy. 2006. PMID: 17117702 Review. No abstract available.
• Licensing Compounds: lessons from ISTA Pharmaceuticals.

  Anido V Jr. Anido V Jr. Retina. 2005 Dec;25(8 Suppl):S98. doi: 10.1097/00006982-200512001-00049. Retina. 2005. PMID: 16374363 Review. No abstract available.